Skip to main content

Morphic Holding, Inc.

MORFDelisted Aug 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001679363

Morphic Holding, Inc. was delisted on Aug 16, 2024; its insiders filed their last Form 4 on Aug 21, 2024; 136 institutions reported holding it in 13F filings for Q2 2024, worth $1.54B in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Morphic Holding, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of MORF: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders106110+4
Shares26.2M26.7M+492.7K (+1.9%)
Value$1.50B$1.51B+$9.07M (+0.6%)

New holders (17)

Institutions that held Morphic Holding, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to MORF in Q3 2021
InstitutionSharesValue% of portfolio
Holocene Advisors, LP259,534$14.7M0.08%
Fiduciary Trust Co214,366$12.1M0.22%
Fred Alger Management, LLC155,618$8.81M0.02%
Citadel Advisors LLC46,293$2.62M0.00%
Eversept Partners, LP43,600$2.47M0.20%
SG Americas Securities, LLC41,014$2.32M0.01%
Tekla Capital Management LLC35,025$1.98M0.06%
Martingale Asset Management L P13,006$738.0K0.01%
AlphaCrest Capital Management LLC9,870$559.0K0.03%
Caas Capital Management LP9,197$521.0K0.04%
Jane Street Group, LLC8,373$474.0K0.00%
Ameriprise Financial Inc3,925$222.0K0.00%
US Bancorp124$7.00K0.00%
TCI Wealth Advisors, Inc.75$4.00K0.00%
Point72 Hong Kong Ltd66$4.00K0.00%
Parallel Advisors, LLC76$4.00K0.00%
Steward Partners Investment Advisory, LLC17$1.00K0.00%

Sold out (13)

Institutions that held Morphic Holding, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.